Skip to main content
. Author manuscript; available in PMC: 2022 May 19.
Published in final edited form as: Pharmacotherapy. 2022 Feb 21;42(4):298–310. doi: 10.1002/phar.2669

TABLE 5.

Pain scores on Numerical Pain Rating Scale (NPRS) at each timepoint (n = 10)

Baseline 5 min 10 min 15 min 30 min 45 min 60 min 120 min 180 min 240 min
Visit one (10-mg intranasal ketamine)
 7.5 (6–8) 6 (5–8) 6 (5–8) 5 (4–7) 4.5 (2–7) 5 (3–7) 4.5 (3–6) 4.5 (3–7) 5 (3–6) 5 (3–7)
 Change from baseline 0.5 (0–2) p = 0.063 0.5 (0–3) p = 0.062 1 (1–2) p = 0.004 1 (1–5) p = 0.004 1 (1–4) p = 0.008 1.5 (1–4) p = 0.002 1.5 (0–3) p = 0.016 2 (0–3) p = 0.016 1.5 (1–2) p = 0.008
Visit two (10-mg intravenous ketamine)
 6 (5–8) 1 (0–3) 0 (0–3) 1.5 (0–3) 2.5 (0–5) 3 (0–5) 3.5 (1–5) 3.5 (1–4) 4 (1–5) 3 (1–4)
 Change from baseline 4 (3–7) p = 0.002 5.5 (3–7) p = 0.002 4.5 (3–6) p = 0.002 2.5 (1–6) p = 0.004 2.5 (1–5) p = 0.004 2 (1–4) p = 0.004 2 (2–4) p = 0.008 1.5 (1–3) p = 0.008 2 (2–3) p = 0.008
Visit three (30-mg intranasal ketamine)
 5.5 (5–7) 5 (4–6) 3 (3–6) 3.5 (3–6) 3.5 (2–6) 3 (2–4) 2.5 (2–3) 3 (2–3) 3 (2–3) 3 (3–4)
 Change from baseline 0.5 (0–1) p = 0.06 2 (2–3) p = 0.04 2 (1–3) p = 0.004 2 (1–3) p = 0.004 2 (2–3) p = 0.004 3 (2–3) p = 0.002 2 (2–4) p = 0.002 2 (1–5) p = 0.004 2 (1–2) p = 0.008
Visit four (50-mg intranasal ketamine)
 6 (6–8) 5 (3–5) 4 (2–5) 3 (2–5) 2 (2–5) 2 (2–4) 2 (1–5) 2 (1–5) 2.5 (1–6) 5 (2–6)
 Change from baseline 1 (0–2) p = 0.047 2 (1–3) p = 0.008 4 (3–4) p = 0.004 4 (2–4) p = 0.004 4 (4–4) p = 0.008 4 (3–5) p = 0.008 4 (2–5) p = 0.008 3 (1–5) p = 0.008 1 (1–4) p = 0.008

Notes: Data presented as median (interquartile range). Shapiro-Wilk test used to test for normality, and more than 80 percent of the time point values were found not to have normal distribution. Therefore, all p-values presented here are for the Wilcoxon signed-rank test for not normally distributed data. Data points with p-values <0.05 are bolded.